Exact Mass: 377.1506104

Exact Mass Matches: 377.1506104

Found 137 metabolites which its exact mass value is equals to given mass value 377.1506104, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Imidaprilat

(4S)-1-Methyl-3-{(2S)-2-[N-((1S)-1-carboxy-3-phenylpropyl)amino]propionyl}-2-oxo-imidazolidine-4-carboxylic acid

C18H23N3O6 (377.1586778)


Imidaprilat, is the active metabolite of Imidapril. Imidapril is a prodrug used to treat hypertension, chronic congestive heart failure (CHF), acute myocardial infarction (AMI), and diabetic nephropathy (PMID: 17547476,18192036,12177688, 17094051). Imidapril belongs to a class of long-acting, non-sulfhydryl angiotensin-converting enzyme (ACE) inhibitors (PMID: 8851752, 12177688). Imidaprilat competitively binds and inhibits the catalytic activity of ACE, which results in a reduction of peripheral resistance and a reduction in systemic blood pressure (BP) (PMID: 17547476). Imidaprilat is only found in individuals that have used or taken imidapril. D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor

   

Reduced haloperidol

4-(4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanol

C21H25ClFNO2 (377.1557752)


Reduced haloperidol is a metabolite of haloperidol. Haloperidol is a typical antipsychotic. It is in the butyrophenone class of antipsychotic medications and has pharmacological effects similar to the phenothiazines. Haloperidol is an older antipsychotic used in the treatment of schizophrenia and acute psychotic states and delirium. (Wikipedia)

   

3-(2-(N-(1-Carboxy-3-phenylpropyl)amino)propionyl)-1-methyl-2-oxoimidazolidine-4-carboxylic acid

3-(2-(N-(1-Carboxy-3-phenylpropyl)amino)propionyl)-1-methyl-2-oxoimidazolidine-4-carboxylic acid

C18H23N3O6 (377.1586778)


D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors

   

3-[2-(4-Fluorophenyl)ethylamino]-1-methyl-4-(2-methyl-1H-indol-3-yl)pyrrole-2,5-dione

3-{[2-(4-fluorophenyl)ethyl]amino}-1-methyl-4-(2-methyl-1H-indol-3-yl)-2,5-dihydro-1H-pyrrole-2,5-dione

C22H20FN3O2 (377.1539472)


   

(+)-16-Hydroxygalwesine

(+)-16-Hydroxygalwesine

C19H23NO7 (377.1474448)


   
   
   
   

pyrrolemarumine 4-O-alpha-L-rhamnopyranoside

pyrrolemarumine 4-O-alpha-L-rhamnopyranoside

C19H23NO7 (377.1474448)


   

bruceolline K

bruceolline K

C19H23NO7 (377.1474448)


An indole alkaloid that is 1,2,3,4-tetrahydrocyclopenta[b]indole substituted by geminal-methyl groups at position 3, an oxo group at position 1 and a beta-D-glucopyranosyloxy group at position 2.It has been isolated from the ethanol extract of the stems of Brucea mollis.

   
   
   
   
   
   
   
   
   
   

Phentolamine mesilate

Phentolamine mesilate

C18H23N3O4S (377.14091980000006)


Phentolamine mesylate (Phentolamine methanesulfonate) is a reversible, non-selective, and orally active blocker of α1 and α2 adrenergic receptor that expands blood vessels to reduce peripheral vascular resistance. Phentolamine mesylate can be used for the research of pheochromocytoma-related hypertension, heart failure and erectile dysfunction[1][2][3].

   
   
   

Ala Asn Ser Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid

C13H23N5O8 (377.1546558)


   

Ala Ser Asn Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C13H23N5O8 (377.1546558)


   

Ala Ser Ser Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C13H23N5O8 (377.1546558)


   

Gly Asn Ser Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-hydroxybutanoic acid

C13H23N5O8 (377.1546558)


   

Gly Asn Thr Ser

(2S)-2-[(2S,3R)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-hydroxybutanamido]-3-hydroxypropanoic acid

C13H23N5O8 (377.1546558)


   

Gly Gln Ser Ser

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid

C13H23N5O8 (377.1546558)


   

Gly Ser Asn Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-hydroxybutanoic acid

C13H23N5O8 (377.1546558)


   

Gly Ser Gln Ser

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-4-carbamoylbutanamido]-3-hydroxypropanoic acid

C13H23N5O8 (377.1546558)


   

Gly Ser Ser Gln

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-hydroxypropanamido]-4-carbamoylbutanoic acid

C13H23N5O8 (377.1546558)


   

Gly Ser Thr Asn

(2S)-2-[(2S,3R)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-hydroxybutanamido]-3-carbamoylpropanoic acid

C13H23N5O8 (377.1546558)


   

Gly Thr Asn Ser

(2S)-2-[(2S)-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C13H23N5O8 (377.1546558)


   

Gly Thr Ser Asn

(2S)-2-[(2S)-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C13H23N5O8 (377.1546558)


   
   
   
   
   

Asn Ala Ser Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid

C13H23N5O8 (377.1546558)


   

Asn Gly Ser Thr

(2S,3R)-2-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-hydroxypropanamido]-3-hydroxybutanoic acid

C13H23N5O8 (377.1546558)


   

Asn Gly Thr Ser

(2S)-2-[(2S,3R)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-hydroxybutanamido]-3-hydroxypropanoic acid

C13H23N5O8 (377.1546558)


   

Asn Ser Ala Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]propanamido]-3-hydroxypropanoic acid

C13H23N5O8 (377.1546558)


   

Asn Ser Gly Thr

(2S,3R)-2-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]acetamido}-3-hydroxybutanoic acid

C13H23N5O8 (377.1546558)


   

Asn Ser Ser Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]propanoic acid

C13H23N5O8 (377.1546558)


   

Asn Ser Thr Gly

2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-hydroxybutanamido]acetic acid

C13H23N5O8 (377.1546558)


   

Asn Thr Gly Ser

(2S)-2-{2-[(2S,3R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxybutanamido]acetamido}-3-hydroxypropanoic acid

C13H23N5O8 (377.1546558)


   

Asn Thr Ser Gly

2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]acetic acid

C13H23N5O8 (377.1546558)


   

Gln Gly Ser Ser

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}-3-hydroxypropanamido]-3-hydroxypropanoic acid

C13H23N5O8 (377.1546558)


   

Gln Ser Gly Ser

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxypropanamido]acetamido}-3-hydroxypropanoic acid

C13H23N5O8 (377.1546558)


   

Gln Ser Ser Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]acetic acid

C13H23N5O8 (377.1546558)


   

Ser Ala Asn Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C13H23N5O8 (377.1546558)


   

Ser Ala Ser Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C13H23N5O8 (377.1546558)


   

Ser Gly Asn Thr

(2S,3R)-2-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-3-carbamoylpropanamido]-3-hydroxybutanoic acid

C13H23N5O8 (377.1546558)


   

Ser Gly Gln Ser

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-4-carbamoylbutanamido]-3-hydroxypropanoic acid

C13H23N5O8 (377.1546558)


   

Ser Gly Ser Gln

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-3-hydroxypropanamido]-4-carbamoylbutanoic acid

C13H23N5O8 (377.1546558)


   

Ser Gly Thr Asn

(2S)-2-[(2S,3R)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-3-hydroxybutanamido]-3-carbamoylpropanoic acid

C13H23N5O8 (377.1546558)


   

Ser Asn Ala Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]propanamido]-3-hydroxypropanoic acid

C13H23N5O8 (377.1546558)


   

Ser Asn Gly Thr

(2S,3R)-2-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]acetamido}-3-hydroxybutanoic acid

C13H23N5O8 (377.1546558)


   

Ser Asn Ser Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]propanoic acid

C13H23N5O8 (377.1546558)


   

Ser Asn Thr Gly

2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-hydroxybutanamido]acetic acid

C13H23N5O8 (377.1546558)


   

Ser Gln Gly Ser

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carbamoylbutanamido]acetamido}-3-hydroxypropanoic acid

C13H23N5O8 (377.1546558)


   

Ser Gln Ser Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carbamoylbutanamido]-3-hydroxypropanamido]acetic acid

C13H23N5O8 (377.1546558)


   

Ser Ser Ala Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]propanamido]-3-carbamoylpropanoic acid

C13H23N5O8 (377.1546558)


   

Ser Ser Gly Gln

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]acetamido}-4-carbamoylbutanoic acid

C13H23N5O8 (377.1546558)


   

Ser Ser Asn Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]-3-carbamoylpropanamido]propanoic acid

C13H23N5O8 (377.1546558)


   

Ser Ser Gln Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]-4-carbamoylbutanamido]acetic acid

C13H23N5O8 (377.1546558)


   

Ser Thr Gly Asn

(2S)-2-{2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]acetamido}-3-carbamoylpropanoic acid

C13H23N5O8 (377.1546558)


   

Ser Thr Asn Gly

2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]-3-carbamoylpropanamido]acetic acid

C13H23N5O8 (377.1546558)


   

Thr Gly Asn Ser

(2S)-2-[(2S)-2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C13H23N5O8 (377.1546558)


   

Thr Gly Ser Asn

(2S)-2-[(2S)-2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C13H23N5O8 (377.1546558)


   

Thr Asn Gly Ser

(2S)-2-{2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carbamoylpropanamido]acetamido}-3-hydroxypropanoic acid

C13H23N5O8 (377.1546558)


   

Thr Asn Ser Gly

2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]acetic acid

C13H23N5O8 (377.1546558)


   

Thr Ser Gly Asn

(2S)-2-{2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]acetamido}-3-carbamoylpropanoic acid

C13H23N5O8 (377.1546558)


   

Thr Ser Asn Gly

2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]-3-carbamoylpropanamido]acetic acid

C13H23N5O8 (377.1546558)


   

Haloperidol (reduced)

4-(4-Chlorophenyl)-a-(4-fluorophenyl)-4-hydroxy-1-piperidinebutanol

C21H25ClFNO2 (377.1557752)


   

Imidaprilat

(4S)-3-[(2S)-2-{[(1S)-1-carboxy-3-phenylpropyl]amino}propanoyl]-1-methyl-2-oxoimidazolidine-4-carboxylic acid

C18H23N3O6 (377.1586778)


A member of the class of imidazolidines that is imidapril in which the ethyl ester group has been hydrolysed to the corresponding acid group. It is the active metabolite of imidapril used to treat hypertension. D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor

   

tert-Butyl (triphenylphosphoranylidene)carbamate

tert-Butyl (triphenylphosphoranylidene)carbamate

C23H24NO2P (377.1544574)


   
   
   

3-(4-Methoxybenzyloxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridinehydrochloride

3-(4-Methoxybenzyloxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridinehydrochloride

C19H25BClNO4 (377.1565070000001)


   

1-(4-nitrophenyl)-1,2,2-triphenylethylene

1-(4-nitrophenyl)-1,2,2-triphenylethylene

C26H19NO2 (377.14157140000003)


   
   
   

(4-(N-Butyl-N-(4-methoxybenzyl)sulfamoyl)phenyl)boronic acid

(4-(N-Butyl-N-(4-methoxybenzyl)sulfamoyl)phenyl)boronic acid

C18H24BNO5S (377.14681640000003)


   

tert-Butyl 5-chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate

tert-Butyl 5-chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate

C19H25BClNO4 (377.1565070000001)


   

tert-Butyl 7-chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate

tert-Butyl 7-chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate

C19H25BClNO4 (377.1565070000001)


   
   

tert-Butyl 6-chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate

tert-Butyl 6-chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate

C19H25BClNO4 (377.1565070000001)


   

5-ethyl-5,10-dihydro-10,10-diphenylphenosilazine

5-ethyl-5,10-dihydro-10,10-diphenylphenosilazine

C26H23NSi (377.1599678)


   

(4-(N-(tert-Butyl)-N-(4-methoxybenzyl)sulfamoyl)phenyl)boronic acid

(4-(N-(tert-Butyl)-N-(4-methoxybenzyl)sulfamoyl)phenyl)boronic acid

C18H24BNO5S (377.14681640000003)


   
   

7-Pyridin-2-Yl-N-(3,4,5-Trimethoxyphenyl)-7h-Pyrrolo[2,3-D]pyrimidin-2-Amine

7-Pyridin-2-Yl-N-(3,4,5-Trimethoxyphenyl)-7h-Pyrrolo[2,3-D]pyrimidin-2-Amine

C20H19N5O3 (377.1487824000001)


   

[4-({5-(Aminocarbonyl)-4-[(3-Methylphenyl)amino]pyrimidin-2-Yl}amino)phenyl]acetic Acid

[4-({5-(Aminocarbonyl)-4-[(3-Methylphenyl)amino]pyrimidin-2-Yl}amino)phenyl]acetic Acid

C20H19N5O3 (377.1487824000001)


   

Phentolamine mesylate

Phentolamine mesylate

C18H23N3O4S (377.14091980000006)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Phentolamine mesylate (Phentolamine methanesulfonate) is a reversible, non-selective, and orally active blocker of α1 and α2 adrenergic receptor that expands blood vessels to reduce peripheral vascular resistance. Phentolamine mesylate can be used for the research of pheochromocytoma-related hypertension, heart failure and erectile dysfunction[1][2][3].

   

1-[(3,5-dimethyl-1H-pyrazol-4-yl)sulfonyl]-N-(5-methyl-2-pyridinyl)-4-piperidinecarboxamide

1-[(3,5-dimethyl-1H-pyrazol-4-yl)sulfonyl]-N-(5-methyl-2-pyridinyl)-4-piperidinecarboxamide

C17H23N5O3S (377.15215280000007)


   

1-[4-(3,4,5-Trimethoxyphenyl)-2-thiazolyl]-4-piperidinecarboxamide

1-[4-(3,4,5-Trimethoxyphenyl)-2-thiazolyl]-4-piperidinecarboxamide

C18H23N3O4S (377.14091980000006)


   

1-(2,5-Dimethoxyphenyl)-3-[5-(2-methylpiperidin-1-yl)-1,3,4-thiadiazol-2-yl]urea

1-(2,5-Dimethoxyphenyl)-3-[5-(2-methylpiperidin-1-yl)-1,3,4-thiadiazol-2-yl]urea

C17H23N5O3S (377.15215280000007)


   

2-cyano-N-(2-furanylmethyl)-2-[3-(4-morpholinyl)-2-quinoxalinyl]acetamide

2-cyano-N-(2-furanylmethyl)-2-[3-(4-morpholinyl)-2-quinoxalinyl]acetamide

C20H19N5O3 (377.1487824000001)


   

1-(3,4-dihydro-1H-isoquinolin-2-yl)-2-[(2-propyl-4-quinazolinyl)thio]ethanone

1-(3,4-dihydro-1H-isoquinolin-2-yl)-2-[(2-propyl-4-quinazolinyl)thio]ethanone

C22H23N3OS (377.15617480000003)


   

(15S)-13-[(4-Fluorophenyl)methyl]-10,10-dimethyl-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione

(15S)-13-[(4-Fluorophenyl)methyl]-10,10-dimethyl-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione

C22H20FN3O2 (377.1539472)


   

(15S)-13-[(2-Fluorophenyl)methyl]-10,10-dimethyl-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione

(15S)-13-[(2-Fluorophenyl)methyl]-10,10-dimethyl-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione

C22H20FN3O2 (377.1539472)


   

(15R)-13-[(4-Fluorophenyl)methyl]-10,10-dimethyl-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione

(15R)-13-[(4-Fluorophenyl)methyl]-10,10-dimethyl-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione

C22H20FN3O2 (377.1539472)


   

(15S)-13-[(3-Fluorophenyl)methyl]-10,10-dimethyl-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione

(15S)-13-[(3-Fluorophenyl)methyl]-10,10-dimethyl-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione

C22H20FN3O2 (377.1539472)


   

(15R)-13-[(2-Fluorophenyl)methyl]-10,10-dimethyl-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione

(15R)-13-[(2-Fluorophenyl)methyl]-10,10-dimethyl-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione

C22H20FN3O2 (377.1539472)


   
   
   
   

4-[(2E)-2-(2,4,5-trimethoxybenzylidene)hydrazinyl]-5H-pyrimido[5,4-b]indole

4-[(2E)-2-(2,4,5-trimethoxybenzylidene)hydrazinyl]-5H-pyrimido[5,4-b]indole

C20H19N5O3 (377.1487824000001)


   

2-[[(1S,5R)-7-[4-(2-methoxyphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]methyl]thiazole

2-[[(1S,5R)-7-[4-(2-methoxyphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]methyl]thiazole

C22H23N3OS (377.15617480000003)


   
   
   
   
   
   
   
   
   
   
   

(8aR)-2-(1-benzothiophen-2-ylmethyl)-7-benzyl-5,6,8,8a-tetrahydro-1H-imidazo[1,5-a]pyrazin-3-one

(8aR)-2-(1-benzothiophen-2-ylmethyl)-7-benzyl-5,6,8,8a-tetrahydro-1H-imidazo[1,5-a]pyrazin-3-one

C22H23N3OS (377.15617480000003)


   

2-(2-Trimethylsilyloxyethoxy)-4-quinolinecarboxylic acid trimethylsilyl ester

2-(2-Trimethylsilyloxyethoxy)-4-quinolinecarboxylic acid trimethylsilyl ester

C18H27NO4Si2 (377.1478542)


   
   

3-[2-(4-Fluorophenyl)ethylamino]-1-methyl-4-(2-methyl-1H-indol-3-yl)pyrrole-2,5-dione

3-[2-(4-Fluorophenyl)ethylamino]-1-methyl-4-(2-methyl-1H-indol-3-yl)pyrrole-2,5-dione

C22H20FN3O2 (377.1539472)


   

H3R antagonist 1 (hydrochloride)

H3R antagonist 1 (hydrochloride)

C19H24ClN3O3 (377.1506104)


H3R antagonist 1 hydrochloride is a histamine receptor 3 (H3R) inverse agonist extracted from patent WO2013107336A1, compound example 2.

   

(1r,2r,3r,7s,8s,10r,15r,17r)-2,7-dihydroxy-8,10,17-trimethyl-6,14,18-trioxa-5-azapentacyclo[10.5.2.1⁴,⁷.0³,¹⁵.0¹⁵,¹⁹]icosa-4,12(19)-diene-11,13-dione

(1r,2r,3r,7s,8s,10r,15r,17r)-2,7-dihydroxy-8,10,17-trimethyl-6,14,18-trioxa-5-azapentacyclo[10.5.2.1⁴,⁷.0³,¹⁵.0¹⁵,¹⁹]icosa-4,12(19)-diene-11,13-dione

C19H23NO7 (377.1474448)


   

2-hydroxy-4-(hydroxyimino)-7,9,16-trimethyl-13,17-dioxatetracyclo[9.5.2.0³,¹⁴.0¹⁴,¹⁸]octadec-11(18)-ene-6,10,12-trione

2-hydroxy-4-(hydroxyimino)-7,9,16-trimethyl-13,17-dioxatetracyclo[9.5.2.0³,¹⁴.0¹⁴,¹⁸]octadec-11(18)-ene-6,10,12-trione

C19H23NO7 (377.1474448)


   

6'-hydroxy-5,6,7'-trimethoxy-4'-methyl-2',3',4'a,6',7',7'a-hexahydrospiro[2-benzofuran-1,5'-oxireno[2,3-d]indol]-3-one

6'-hydroxy-5,6,7'-trimethoxy-4'-methyl-2',3',4'a,6',7',7'a-hexahydrospiro[2-benzofuran-1,5'-oxireno[2,3-d]indol]-3-one

C19H23NO7 (377.1474448)


   

2,7-dihydroxy-8,10,17-trimethyl-6,14,18-trioxa-5-azapentacyclo[10.5.2.1⁴,⁷.0³,¹⁵.0¹⁵,¹⁹]icosa-4,12(19)-diene-11,13-dione

2,7-dihydroxy-8,10,17-trimethyl-6,14,18-trioxa-5-azapentacyclo[10.5.2.1⁴,⁷.0³,¹⁵.0¹⁵,¹⁹]icosa-4,12(19)-diene-11,13-dione

C19H23NO7 (377.1474448)


   

(1r,1'ar,4'ar,6'r,7'r,7'as)-6'-hydroxy-5,6,7'-trimethoxy-4'-methyl-2',3',4'a,6',7',7'a-hexahydrospiro[2-benzofuran-1,5'-oxireno[2,3-d]indol]-3-one

(1r,1'ar,4'ar,6'r,7'r,7'as)-6'-hydroxy-5,6,7'-trimethoxy-4'-methyl-2',3',4'a,6',7',7'a-hexahydrospiro[2-benzofuran-1,5'-oxireno[2,3-d]indol]-3-one

C19H23NO7 (377.1474448)


   

(1r,2s,6r,8s,9s,10r)-1-hydroxy-9,15,16-trimethoxy-3-methyl-7,11-dioxa-3-azapentacyclo[8.8.0.0²,⁶.0⁶,⁸.0¹³,¹⁸]octadeca-13(18),14,16-trien-12-one

(1r,2s,6r,8s,9s,10r)-1-hydroxy-9,15,16-trimethoxy-3-methyl-7,11-dioxa-3-azapentacyclo[8.8.0.0²,⁶.0⁶,⁸.0¹³,¹⁸]octadeca-13(18),14,16-trien-12-one

C19H23NO7 (377.1474448)


   

5-(hydroxymethyl)-1-[(4-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}phenyl)methyl]pyrrole-2-carbaldehyde

5-(hydroxymethyl)-1-[(4-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}phenyl)methyl]pyrrole-2-carbaldehyde

C19H23NO7 (377.1474448)


   

1-hydroxy-9,15,16-trimethoxy-3-methyl-7,11-dioxa-3-azapentacyclo[8.8.0.0²,⁶.0⁶,⁸.0¹³,¹⁸]octadeca-13(18),14,16-trien-12-one

1-hydroxy-9,15,16-trimethoxy-3-methyl-7,11-dioxa-3-azapentacyclo[8.8.0.0²,⁶.0⁶,⁸.0¹³,¹⁸]octadeca-13(18),14,16-trien-12-one

C19H23NO7 (377.1474448)


   

(1r,5's,6'r,7'ar)-5',6'-dihydroxy-4,5,6-trimethoxy-1'-methyl-3',5',6',7'a-tetrahydro-2'h-spiro[2-benzofuran-1,7'-indol]-3-one

(1r,5's,6'r,7'ar)-5',6'-dihydroxy-4,5,6-trimethoxy-1'-methyl-3',5',6',7'a-tetrahydro-2'h-spiro[2-benzofuran-1,7'-indol]-3-one

C19H23NO7 (377.1474448)


   

(1r,2r,3r,4z,7s,9r,14r,16r)-2-hydroxy-4-(hydroxyimino)-7,9,16-trimethyl-13,17-dioxatetracyclo[9.5.2.0³,¹⁴.0¹⁴,¹⁸]octadec-11(18)-ene-6,10,12-trione

(1r,2r,3r,4z,7s,9r,14r,16r)-2-hydroxy-4-(hydroxyimino)-7,9,16-trimethyl-13,17-dioxatetracyclo[9.5.2.0³,¹⁴.0¹⁴,¹⁸]octadec-11(18)-ene-6,10,12-trione

C19H23NO7 (377.1474448)